The actinic keratosis treatment market is expected to grow from USD 6.13 billion in 2024 to USD 12.28 billion by 2034, at a CAGR of 7.2%. Increasing concerns over skin cancer and advancements in ...
The severity of skin reactions to the treatment of actinic keratosis with 5-fluorouracil cream 4% was associated with a higher lesion clearance rate.
Higher incidences of actinic keratosis (AK) after solid organ transplant occurred in men, White individuals, and lung ...
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer, among which 82% arise from actinic keratosis (AK) characterized by lesions of epidermal keratinocyte ...